0 Comentários
0 Compartilhamentos
385 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Anti-Obesity Medication Market: The Rising Impact of GLP-1 Drugs on Weight Loss TreatmentPolaris Market Research presents its latest market research report, titled Anti-Obesity Medication Market. It is a comprehensive market research report analyzing the fast-evolving anti-obesity medication market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of...0 Comentários 0 Compartilhamentos 291 Visualizações 0 Anterior
-
Exploring the Future of the GLP-1 Analogues Market in Diabetes CareDemographic Drivers The GLP-1 analogues market, valued at USD 56.62 billion in 2025 and projected to grow at a CAGR of 21.39% from 2026 to 2034, is supported by expanded regulatory approvals for chronic weight management and cardiovascular risk reduction. Demographics add to this momentum. The geriatric population is at higher risk of diabetes and related conditions, and the report cites the UN...0 Comentários 0 Compartilhamentos 713 Visualizações 0 Anterior
-
Global GLP-1 Market Forecast 2026–2034: Revenue to Reach USD 133.92 BillionGLP-1 Market to Reach USD 133.92 Billion by 2034, Growing at 10.9% CAGR: Polaris Market Research According to Polaris Market Research, the global GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034. The market is estimated at USD 58.48 billion in 2026 and is expected to grow at a CAGR of 10.9% during 2026–2034. Expansion is being...0 Comentários 0 Compartilhamentos 216 Visualizações 0 Anterior
-
GLP-1 Analogues Market Outlook Strengthened by Rising Prevalence of Metabolic DisordersThe global GLP-1 Analogues Market is experiencing unprecedented growth as healthcare providers increasingly adopt innovative therapies for managing type 2 diabetes and obesity. According to Polaris Market Research, the market was valued at USD 46.70 billion in 2024 and is projected to grow from USD 56.62 billion in 2025 to USD 322.85 billion by 2034, registering a remarkable CAGR of 21.3%...0 Comentários 0 Compartilhamentos 601 Visualizações 0 Anterior
-
GLP-1 Analogues Market: Forecast Shows 21.39% CAGR Through 2034GLP-1 Analogues Market: Projected to Reach USD 324.15 Billion by 2034 Polaris Market Research projects the GLP-1 Analogues Market to advance from USD 68.50 Billion in 2026 to USD 324.15 Billion by 2034, reflecting a 21.39% compound annual growth rate during 2026–2034. The 2025 baseline was USD 56.62 billion. The projection places renewed attention on the business factors shaping...0 Comentários 0 Compartilhamentos 180 Visualizações 0 Anterior
-
GLP-1 Market Outlook: Expanding Opportunities in Metabolic CareMarket Overview Polaris Market Research’s latest research report, titled GLP-1 Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a market defined by...0 Comentários 0 Compartilhamentos 243 Visualizações 0 Anterior
-
GLP-1 Market: Emerging Therapeutic Innovations and Industry OutlookThe GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...0 Comentários 0 Compartilhamentos 289 Visualizações 0 Anterior
-
GLP-1 Receptor Agonist Market Expected to Reach USD 7.9 Billion by 2036, India - CAGR 8.4%, China - CAGR 7.1%, Germany - CAGR 6.6%The global GLP-1 receptor agonist market growing from USD 3 billion in 2026 to USD 7.9 billion by 2036, expanding at a CAGR of 11.7% during the forecast period. The market is gaining momentum as type 2 diabetes and obesity become more widespread, while GLP-1 therapies offer combined benefits for blood sugar management, appetite reduction, and weight control. The market is expected to add USD...0 Comentários 0 Compartilhamentos 210 Visualizações 0 Anterior
-
Understanding the Global GLP-1 Market Size and Growth PotentialAccording to a new report by Polaris Market Research, the global GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034, expanding at a CAGR of 10.9% over the forecast period. Growth is underpinned by rising type 2 diabetes prevalence, expanding demand for obesity treatment, and accelerating adoption of oral and long-acting drug formulations...0 Comentários 0 Compartilhamentos 288 Visualizações 0 Anterior
-
Pen Needles Market: Europe Maintains Leadership as Asia Pacific AcceleratesThe pen needles market is increasingly being shaped by a simple healthcare priority: making injectable therapies easier and more comfortable to manage. As diabetes prevalence continues to rise and more patients administer medications at home, Pen Needles Market are becoming an important part of everyday disease management. The global market was valued at USD 4.8 billion in 2025 and is projected...0 Comentários 0 Compartilhamentos 356 Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
